A Comparative Bioavailability Study of Tamsulosin 0.4 mg Prolonged-release Tablets Versus the Reference Drug Omnic Ocas®, Tamsulosin Hydrochloride 0.4 mg, Prolonged-release Film-coated Tablets, in Healthy Adult Male Subjects, Under Fasting Conditions

Clinical trial NCT07156916 · RECRUITING

Trial details

NCT number: NCT07156916
Sponsor: Berlin-Chemie AG Menarini Group
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Volunteer Male Subjects

Start date: 2025-09-08
Primary completion: 2026-03-01
Enrollment: 46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.